Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.50
29.04.24
€100.00
31.03.26
-0.75%
03.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.73
25.04.24
-
25.04.25
0.80%
27.04.24

Risky Investment
Global_Player 
25.04.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-2.00%
27.04.24

Could be worthwhile Investment >10% per year
Global_Player 
25.04.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.07
19.04.24
-
19.04.25
-10.90%
28.04.24

Could be very worthwhile Investment >20% year
michaelkr 
19.04.24 50%
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.66
14.04.24
-
14.04.25
-13.86%
28.04.24

Could be worthwhile Investment >10% per year
thomasw 
14.04.24 50%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
nvestor 
13.04.24 50%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-32.36%
27.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
nvestor 
13.04.24 50%
sell
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-0.66%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
nvestor 
13.04.24 50%
buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.72
11.04.24
-
11.04.25
-12.21%
14.04.24

Could be worthwhile Investment >10% per year
Wolf_of_WS 
11.04.24 50%
sell
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.50
11.04.24
-
11.04.25
3.27%
14.04.24

Risky Investment
Global_Player 
11.04.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€66.50
07.04.24
-
07.04.25
0.75%
14.04.24

Could be very worthwhile Investment >20% year
Vassago1 
07.04.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.88
26.03.24
-
26.03.25
-18.09%
31.03.24

Risky Investment
Vassago1 
26.03.24 50%
sell
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€1.06
26.03.24
-
26.03.25
-1.69%
31.03.24

Risky Investment
Vassago1 
26.03.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.22
21.03.24
-
21.03.25
2.97%
29.03.24

Probably not worthwhile Investment
thomasw 
21.03.24 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
18.03.24
-
18.03.25
2.26%
30.03.24

Could be worthwhile Investment >10% per year
Wolf_of_WS 
18.03.24 50%
sell
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
17.03.24
€0.30
30.11.25
76.96%
28.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.71
17.03.24
€5.00
31.01.26
-2.70%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
17.03.24
€16.00
30.06.26
-8.82%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€2.22
16.03.24
€4.00
16.03.25
53.15%
30.03.24

EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€4.89
16.03.24
€48.00
16.03.25
-12.06%
30.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Geron Corp.

Start price
Target price
Perf. (%)
€1.68
12.03.24
-
12.03.25
81.49%
15.03.24

Could be very worthwhile Investment >20% year
Global_Player 
12.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.78
11.03.24
€28.00
11.03.25
6.63%
28.03.24

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
11.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.78
11.03.24
€28.00
11.03.25
6.63%
28.03.24

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
11.03.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€64.50
08.03.24
-
08.03.25
-8.53%
15.03.24

Could be worthwhile Investment >10% per year
Global_Player 
08.03.24 50%